USD 0.0
(-99.67%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -26.07 Million USD | 13.4% |
2022 | -30.11 Million USD | -992.6% |
2021 | -2.75 Million USD | 81.67% |
2020 | -15.03 Million USD | -653.61% |
2019 | 2.71 Million USD | -37.13% |
2018 | 4.32 Million USD | 178.53% |
2017 | -5.5 Million USD | -10072.67% |
2016 | -54.07 Thousand USD | -97.59% |
2015 | -27.36 Thousand USD | 42.91% |
2014 | -47.94 Thousand USD | -19.6% |
2013 | -40.08 Thousand USD | 76.63% |
2012 | -171.52 Thousand USD | -175.7% |
2011 | -62.21 Thousand USD | 8.97% |
2010 | -68.34 Thousand USD | 22.87% |
2009 | -88.6 Thousand USD | -32.18% |
2008 | -67.03 Thousand USD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q1 | -3.76 Million USD | 58.5% |
2024 Q2 | -3.84 Million USD | 93.22% |
2023 Q3 | -7.43 Million USD | -41.37% |
2023 FY | -26.07 Million USD | 13.4% |
2023 Q1 | -4.31 Million USD | 79.93% |
2023 Q2 | -5.26 Million USD | -21.97% |
2023 Q4 | -9.06 Million USD | -21.83% |
2022 Q2 | -4.72 Million USD | -92.19% |
2022 Q3 | -1.43 Million USD | 69.68% |
2022 Q4 | -21.49 Million USD | -1399.93% |
2022 Q1 | -2.45 Million USD | -695.79% |
2022 FY | -30.11 Million USD | -992.6% |
2021 Q4 | -309 Thousand USD | -439.56% |
2021 Q2 | -1.3 Million USD | -6.17% |
2021 Q3 | 91 Thousand USD | 106.96% |
2021 FY | -2.75 Million USD | 81.67% |
2021 Q1 | -1.23 Million USD | -146.69% |
2020 Q2 | -12.97 Million USD | -2125.9% |
2020 Q4 | -499 Thousand USD | 48.93% |
2020 FY | -15.03 Million USD | -653.61% |
2020 Q1 | -583 Thousand USD | 91.42% |
2020 Q3 | -977 Thousand USD | 92.47% |
2019 Q3 | 3.66 Million USD | -9.03% |
2019 Q4 | -6.79 Million USD | -285.15% |
2019 FY | 2.71 Million USD | -37.13% |
2019 Q1 | 1.73 Million USD | 134.51% |
2019 Q2 | 4.03 Million USD | 131.91% |
2018 Q1 | 2.96 Million USD | 124.33% |
2018 FY | 4.32 Million USD | 178.53% |
2018 Q4 | -5.03 Million USD | -261.65% |
2018 Q3 | 3.11 Million USD | -4.86% |
2018 Q2 | 3.27 Million USD | 10.52% |
2017 Q3 | 1.3 Million USD | -39.71% |
2017 Q4 | -12.18 Million USD | -1032.77% |
2017 Q1 | 3.21 Million USD | 15209.11% |
2017 FY | -5.5 Million USD | -10072.67% |
2017 Q2 | 2.16 Million USD | -32.54% |
2016 Q4 | -21.26 Thousand USD | -14.3% |
2016 Q1 | -4210.19 USD | 49.37% |
2016 FY | -54.07 Thousand USD | -97.59% |
2016 Q2 | -10.37 Thousand USD | -146.46% |
2016 Q3 | -18.6 Thousand USD | -79.29% |
2015 Q3 | -7360.15 USD | -24.97% |
2015 FY | -27.36 Thousand USD | 42.91% |
2015 Q1 | -6615.40 USD | 38.98% |
2015 Q2 | -5889.75 USD | 10.97% |
2015 Q4 | -8315.22 USD | -12.98% |
2014 FY | -47.94 Thousand USD | -19.6% |
2014 Q3 | -7508.65 USD | 65.05% |
2014 Q4 | -10.84 Thousand USD | -44.4% |
2014 Q1 | -9144.37 USD | 52.04% |
2014 Q2 | -21.48 Thousand USD | -134.97% |
2013 Q1 | -9106.10 USD | 79.56% |
2013 FY | -40.08 Thousand USD | 76.63% |
2013 Q4 | -19.06 Thousand USD | -333.87% |
2013 Q3 | -4394.23 USD | 41.38% |
2013 Q2 | -7496.01 USD | 17.68% |
2012 FY | -171.52 Thousand USD | -175.7% |
2012 Q1 | -41.47 Thousand USD | -1.29% |
2012 Q2 | -56.22 Thousand USD | -35.56% |
2012 Q3 | -26.82 Thousand USD | 52.29% |
2012 Q4 | -44.55 Thousand USD | -66.11% |
2011 Q4 | -40.95 Thousand USD | -319.78% |
2011 Q1 | -6341.12 USD | 73.93% |
2011 Q2 | -5968.90 USD | 5.87% |
2011 Q3 | -9755.23 USD | -63.43% |
2011 FY | -62.21 Thousand USD | 8.97% |
2010 Q3 | -21.72 Thousand USD | -156.44% |
2010 FY | -68.34 Thousand USD | 22.87% |
2010 Q4 | -24.32 Thousand USD | -11.96% |
2010 Q2 | -8471.68 USD | 38.64% |
2010 Q1 | -13.8 Thousand USD | 76.67% |
2009 FY | -88.6 Thousand USD | -32.18% |
2009 Q4 | -59.17 Thousand USD | -891.98% |
2009 Q3 | -5965.01 USD | 26.25% |
2009 Q2 | -8088.20 USD | 34.94% |
2009 Q1 | -12.43 Thousand USD | -2075.66% |
2008 FY | -67.03 Thousand USD | 0.0% |
2008 Q3 | -20.13 Thousand USD | 54.61% |
2008 Q2 | -44.35 Thousand USD | -1071.57% |
2008 Q1 | -3786.07 USD | 0.0% |
2008 Q4 | -571.38 USD | 97.16% |
Name | Net Income | Net Income Difference |
---|---|---|
American Oncology Network, Inc. | -5.54 Million USD | -370.552% |
ATI Physical Therapy, Inc. | -69.79 Million USD | 62.636% |
Novo Integrated Sciences, Inc. | -13.21 Million USD | -97.343% |
Panamera Holdings Corporation | -7.12 Million USD | -266.025% |